GE Vernova (NYSE:GEV – Free Report) had its price target raised by The Goldman Sachs Group from $324.00 to $400.00 in a research note published on Thursday,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock.
Other equities research analysts also recently issued research reports about the company. Hsbc Global Res downgraded GE Vernova from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 4th. Wolfe Research began coverage on GE Vernova in a report on Wednesday, December 4th. They issued an “outperform” rating and a $403.00 price target on the stock. Barclays boosted their price objective on GE Vernova from $320.00 to $420.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Morgan Stanley raised their target price on shares of GE Vernova from $301.00 to $367.00 and gave the company an “overweight” rating in a research note on Friday, November 15th. Finally, Deutsche Bank Aktiengesellschaft began coverage on shares of GE Vernova in a research note on Monday, October 21st. They issued a “buy” rating and a $354.00 price target for the company. Seven equities research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, GE Vernova has an average rating of “Moderate Buy” and a consensus price target of $314.35.
Get Our Latest Stock Analysis on GE Vernova
GE Vernova Trading Up 0.6 %
GE Vernova Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 28th. Shareholders of record on Friday, December 20th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 0.30%. The ex-dividend date of this dividend is Friday, December 20th.
GE Vernova declared that its board has initiated a stock buyback plan on Tuesday, December 10th that allows the company to buyback $6.00 billion in outstanding shares. This buyback authorization allows the company to repurchase up to 6.7% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its shares are undervalued.
Institutional Trading of GE Vernova
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. FMR LLC lifted its position in shares of GE Vernova by 2.5% in the 3rd quarter. FMR LLC now owns 24,047,678 shares of the company’s stock worth $6,131,677,000 after purchasing an additional 584,208 shares during the period. State Street Corp lifted its holdings in GE Vernova by 1.1% in the third quarter. State Street Corp now owns 10,434,917 shares of the company’s stock worth $2,660,695,000 after buying an additional 118,184 shares during the period. Mountaineer Partners Management LLC bought a new stake in GE Vernova during the 3rd quarter valued at approximately $2,507,296,000. Geode Capital Management LLC grew its holdings in shares of GE Vernova by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 5,594,223 shares of the company’s stock worth $1,420,763,000 after acquiring an additional 80,479 shares during the period. Finally, Newport Trust Company LLC bought a new position in shares of GE Vernova in the 2nd quarter worth approximately $650,140,000.
About GE Vernova
GE Vernova LLC, an energy business company, generates electricity. It operates under three segments: Power, Wind, and Electrification. The Power segments generates and sells electricity through hydro, gas, nuclear, and steam power. Wind segment engages in the manufacturing and sale of wind turbine blades; and Electrification segment provides grid solutions, power conversion, solar, and storage solutions.
Recommended Stories
- Five stocks we like better than GE Vernova
- How to Start Investing in Real Estate
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Buy P&G Now, Before It Sets A New All-Time High
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for GE Vernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE Vernova and related companies with MarketBeat.com's FREE daily email newsletter.